优先次序
计算机科学
数据科学
药物发现
计算生物学
序列(生物学)
转化研究
编码(集合论)
软件工程
抗菌肽
合成生物学
知识抽取
作者
Aarti Krishnan,Hanqun Cao,James J. Collins,César de la Fuente‐Núñez
标识
DOI:10.1126/scitranslmed.aee4629
摘要
Artificial intelligence (AI) now enables the exploration of vast chemical and sequence spaces, the design of synthesizable antibiotics, and the prioritization of safe, mechanism-diverse candidates through integrated modeling and accelerated testing. Here, we survey recent advances in AI for both small-molecule and peptide antimicrobial drugs, highlight emerging data and reporting standards, and outline translational pathways and regulatory hurdles needed to bring these agents to patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI